A 50-year-old woman with a strong family history of breast cancer (mother diagnosed at age 48) attends the GP requesting HRT for vasomotor symptoms. She has a uterus. According to NICE NG23, which statement about HRT and breast cancer risk is most appropriate to inform her decision?